4.6 Article

Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease

Antonella Cardinale et al.

Summary: Parkinson's disease is characterized by the aggregation of alpha-synuclein protein in brain regions and the loss of dopaminergic neurons, which leads to synaptic alterations and immune system activation. Toxic species of alpha-syn, such as oligomers and protofibrils, impair synaptic protein distribution and neurotransmitter release, while inflammatory response mediated by microglia and astrocytes is linked to alpha-syn accumulation in the central nervous system.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity

Simona S. Ghanem et al.

Summary: The accumulation and aggregation of alpha-synuclein is a key pathological event in Parkinson's disease and related disorders. Screening natural alkaloid compounds from Chinese medicinal herbs, researchers identified six compounds that inhibit alpha-synuclein-seeded fibril formation and toxicity, suggesting a promising therapeutic strategy for synucleinopathies.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor

Kseniia Afitska et al.

JOURNAL OF MOLECULAR BIOLOGY (2020)

Review Clinical Neurology

Possible therapies of Parkinson's disease: A review

Ashok Chakraborty et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2020)

Article Biotechnology & Applied Microbiology

Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm

Samuel Pena-Diaz et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Biochemistry & Molecular Biology

Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease

Serena Vittorio et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)

Review Pharmacology & Pharmacy

Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models

Hayate Javed et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Chemistry, Medicinal

Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation

Valentina Oliveri

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

α-Synuclein Dimers as Potent Inhibitors of Fibrillization

Yevhenii A. Kyriukha et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Neurosciences

Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's Disease

Ivan Carrera et al.

CURRENT NEUROPHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Natural compound safranal driven inhibition and dis-aggregation of α-synuclein fibrils

Shreyada S. Save et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)

Article Neurosciences

ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization

Samuel Pena-Diaz et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Neurosciences

Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease

Carroll Rutherford Fields et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease

Fatma Haddad et al.

MOLECULES (2018)

Article Neurosciences

N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice

Rosalia Crupi et al.

MOLECULAR NEUROBIOLOGY (2018)

Review Cell Biology

Subcellular localization of alpha-synuclein aggregates and their interaction with membranes

Fabiana Miraglia et al.

NEURAL REGENERATION RESEARCH (2018)

Article Multidisciplinary Sciences

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

Jordi Pujols et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Neurosciences

Emerging Treatment Approaches for Parkinson's Disease

Thomas B. Stoker et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Biochemistry & Molecular Biology

High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors

Jordi Pujols et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Neurosciences

Prying into the Prion Hypothesis for Parkinson's Disease

Patrik Brundin et al.

JOURNAL OF NEUROSCIENCE (2017)

Article Multidisciplinary Sciences

Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation

LC Serpell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)